This news release did a good job of explaining how the study was done but didn’t provide data on benefits, costs, or harms.
The story mostly just rehashes a drug company news release.
All missing from this news release: benefits, harms, how it compares to other methods to treat aneurysms, cost, and if it’s available beyond one hospital.
Did the study findings really earn a label of “game-changing?”
The news release suggests results from lung tests in infants can predict future lung health. But the research can’t yet tell us that vitamin c use in pregnancy will result in any changes in lung health later on.
This story could have provided a bit more on costs, alternatives, and how this study was performed.
Follow-up studies are needed to confirm these results in more patients across a range of different cancers.
This news release offers no caution about harms nor the fact that benefits found in animal studies seldom translate to humans.
Hard to find the journalism in this brief Reuters story on clinical trial results for psoriasis drug https://t.co/P9ZOmYpQX4
Tips & Resources for Analyzing Health Care Claims
Podcast: The top 10 quotes of 2018
Podcast: Our team reflects on what we’ve learned
Podcast: The polluted stream of health care information